Purchase Order 75N96022P00203
- Not listed
- This is a firm fixed-price purchase order contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Standard Biotools Inc., doing business as Fluidigm. The $24,480.00 contract is for laboratory testing services and does not have a small business set-aside designation. Fluidigm is a for-profit manufacturer of advanced scientific instruments, reagents, and associated products and services used in biomedical, environmental, and healthcare...
- This is a $13,797 firm fixed-price purchase order contract awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a civilian federal agency, to Standard Biotools Inc., doing business as Fluidigm. The contract is not set aside for small businesses. Fluidigm is a for-profit manufacturer of advanced scientific instruments, reagents, and associated products and services, primarily serving biomedical, environmental, and healthcare research markets. This contract...
- This federal contract award, valued at $39,730.50, was issued by a civilian U.S. government agency to Standard Biotools Inc., doing business as Fluidigm, a for-profit manufacturer of advanced scientific instruments, reagents, and associated products and services. The contract is for the procurement of a FLUIDIGM 96.96 GT SAMPLE/LOADING AND SNP TYPE REAGENT KIT-10 IFCS. This purchase order-type contract has a firm fixed price pricing structure and an ultimate completion date of October 26,...
- The Department of Health and Human Services National Institutes of Health National Institute of Environmental Health Sciences awarded a $13,911.60 firm-fixed price purchase order to Standard Biotools Inc., doing business as Fluidigm, for invoice and payment provisions. The award does not have a set-aside designation. Fluidigm is a manufacturer of scientific products and instruments that has provided a variety of goods and services to U.S. federal agencies through both prime and sub-contracts...
- This is a firm fixed-price purchase order contract awarded by a civilian federal agency to Standard Biotools Inc., doing business as Fluidigm, for $9,650.00. The contract does not have a set-aside designation and is for the delivery of specialized scientific equipment and solutions. Fluidigm is a for-profit manufacturer of advanced scientific instruments, reagents, and associated products and services, primarily serving biomedical, environmental, and healthcare research markets. The company...
- This is a $24,795 firm-fixed-price purchase order contract awarded by the National Cancer Institute to Standard Biotools Inc., doing business as Fluidigm, for laboratory testing services. The contract has an ultimate completion date of December 31, 2025 and was not set aside for small businesses. Fluidigm is a for-profit manufacturer of advanced scientific instruments, reagents, and associated products and services, with a robust history of federal contracting across various government...
- This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID) to Standard Biotools Inc., doing business as Fluidigm, for the procurement of a C1 single-cell AutoPrep System. The $140,000.00 firm fixed-price purchase order does not have a small business set-aside designation. Fluidigm is an established manufacturer of specialized scientific instruments, reagents, and associated products and services that supports biomedical and environmental research...
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Standard Biotools Inc., doing business as Fluidigm, a for-profit manufacturer of specialized scientific instruments and reagents. The $42,900.00 firm fixed-price purchase order is for the delivery of GENE EXPRESSION DYNAMIC ARRAY CHIPS, which are likely consumable laboratory products to support NIAID's biomedical research...
- This is a federal contract award from a civilian agency to Standard Biotools Inc., doing business as Fluidigm, a for-profit manufacturer of scientific instruments, reagents, and associated products and services. The contract, valued at $11,624.40, is for the provision of 10 units of a 96.96 GT Sample/Loading and SNP Type Reagent Kit, which includes Dynamic Array Integrated Fluidic Circuits (IFCs) for genotyping and control line fluid syringes and reagents. The contract has a completion date of...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm-fixed price purchase order contract to Standard Biotools Inc., doing business as Fluidigm, for the provision of a laboratory instrument. The $122,580.34 contract has a performance period ending on May 30, 2023 and does not include any set-aside designation. Fluidigm is a for-profit manufacturer that has received over 50 prime federal contract awards from agencies such as the National...
This firm-fixed-price purchase order was awarded to Standard Biotools Inc., doing business as Fluidigm, by the National Institute for Minority Health and Health Disparities (NIMHD), a civilian agency under the National Institutes of Health (NIH). The $557,331.51 contract is for the delivery of Fluidigm's scientific instruments, reagents, genotyping arrays, antibodies, and associated maintenance services to support the agency's research efforts. Fluidigm is a for-profit manufacturer that specializes in providing products and services in fields such as cancer, inflammatory diseases, immunotherapies, and environmental monitoring. This contract did not have a set-aside designation. Fluidigm has extensive experience as both a prime contractor and subcontractor, having received over 50 federal contract awards from various agencies including the CDC, VA, USDA, and EPA.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00003 | Exercise an Option | $113.4k | 6/6/24 | |
| P00002 | Funding Only Action | $110.1k | 8/31/23 | |
| P00001 | Exercise an Option | $0 | 8/21/23 | |
| Not listed | Not listed | $106.9k | 8/30/22 |